{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This triple\u2010blind, non\u2010inferiority, clinical trial randomly allocated patients aged 40\u201385 who underwent elective aortic valve replacement, with or without coronary artery bypass grafting, to plasma volume replacement with 6% starch 130/0.4 vs. 5% human albumin."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This triple\u2010blind, non\u2010inferiority, clinical trial randomly allocated patients aged 40\u201385 who underwent elective aortic valve replacement, with or without coronary artery bypass grafting, to plasma volume replacement with 6% starch 130/0.4 vs. 5% human albumin."
      },
      "Participants": {
        "score": 2,
        "evidence": "patients aged 40\u201385 who underwent elective aortic valve replacement, with or without coronary artery bypass grafting"
      },
      "Intervention": {
        "score": 2,
        "evidence": "to plasma volume replacement with 6% starch 130/0.4 vs. 5% human albumin"
      },
      "Objective": {
        "score": 1,
        "evidence": "We tested the hypotheses that intra\u2010operative administration of a third\u2010generation starch does not worsen postoperative kidney function or haemostasis in cardiac surgical patients compared with human albumin 5%."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Our primary outcome was postoperative urinary neutrophil gelatinase\u2010associated lipocalin concentrations, a sensitive and early marker of postoperative kidney injury."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomly allocated patients"
      },
      "Blinding": {
        "score": 3,
        "evidence": "This triple\u2010blind, non\u2010inferiority, clinical trial"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "We enrolled 141 patients (69 starch, 72 albumin) as planned."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Results of the primary analysis demonstrated that postoperative urine neutrophil gelatinase\u2010associated lipocalin (median ( IQR [range])) was slightly lower with hydroxyethyl starch (5 (1\u201368 [0\u2013996]) ng.ml \u22121 ) vs. albumin (5 (2\u201374 [0\u20131604]) ng.ml \u22121 ), although not non\u2010inferior [ratio of geometric means (95% CI ) 0.91 (0.57, 1.44); p = 0.15] due to higher than expected variability."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}